Plasticity-based Adaptive Cognitive Remediation for Alzheimers Disease Phase II

Information

  • Research Project
  • 9551481
  • ApplicationId
    9551481
  • Core Project Number
    R44AG047722
  • Full Project Number
    5R44AG047722-05
  • Serial Number
    047722
  • FOA Number
    PA-15-052
  • Sub Project Id
  • Project Start Date
    9/30/2014 - 9 years ago
  • Project End Date
    4/30/2020 - 4 years ago
  • Program Officer Name
    MCLINDEN, KRISTINA
  • Budget Start Date
    5/15/2018 - 6 years ago
  • Budget End Date
    4/30/2019 - 5 years ago
  • Fiscal Year
    2018
  • Support Year
    05
  • Suffix
  • Award Notice Date
    5/11/2018 - 6 years ago

Plasticity-based Adaptive Cognitive Remediation for Alzheimers Disease Phase II

Project Summary Abstract The primary objective of the current project is to improve and evaluate the efficacy of on-line brain plasticity- based computerized assessment tool and training program for the prevention and delay of the onset of Alzheimer?s disease (AD). This novel therapeutic strategy is designed 1) to increase feed-forward power in brain systems in ways that are designed to reactivate them, and 2) to directly exercise highest-level neurological (DN) processes. We will rapidly develop an enhanced PACR-AD 2.0 program with older adult specific website wrapper, video instructions and motivation videos, which will facilitate greater program engagement and adherence. Next, we will launch a large sample, two-site, double-blind RCT of the program with older adults. This RCT will be powered for clinically significant efficacy outcomes; in it, PACR-AD 2.0 will be compared to an active control of computer games that are matched for the multiple factors of challenge, computer time and research staff interaction during the intervention period. For the intervention trial, we have partnered with University of Iowa and University of Texas at Dallas. These sites will comprehensively evaluate immediate as well as sustained outcomes of the PACR-AD 2.0 vs. control intervention in cognitive, functional and, neurological measures. Successful evaluation of PACR-AD 2.0 will be used to obtain FDA clearance for the program and commercialize it as the first evidence-based prevention device indicated for age-related cognitive decline. Given the ease of access of online-based assessment and training, this project should result in the development of a new, powerful tool to assess and prevent the risk of onset of AD, and to provide effective adjunctive therapy that results in far greater resilience against cognitive impairment in a substantially greater pre-AD population.

IC Name
NATIONAL INSTITUTE ON AGING
  • Activity
    R44
  • Administering IC
    AG
  • Application Type
    5
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    614709
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    866
  • Ed Inst. Type
  • Funding ICs
    NIA:614709\
  • Funding Mechanism
    SBIR-STTR RPGs
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    POSIT SCIENCE CORPORATION
  • Organization Department
  • Organization DUNS
    141662283
  • Organization City
    SAN FRANCISCO
  • Organization State
    CA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    941115513
  • Organization District
    UNITED STATES